← Eichor
Condition: Psoriasis Pso Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Psoriasis Pso

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Global Healthcare Study on Psoriasis
Phase N/A · 1 location(s) · Julia Tatjana Maul · NCT07634016A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · 18 location(s) · Huabo Biopharm Co., Ltd. · NCT06592274A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
Phase 2 · 1 location(s) · Ahmed Ibrahim · NCT07233291A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · 40 location(s) · Eli Lilly and Company · NCT06857942Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Phase 4 · 1 location(s) · Hospital Universitario Dr. Jose E. Gonzalez · NCT07401992A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT07298265A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants Wit
Phase 3 · 129 location(s) · Bristol-Myers Squibb · NCT06979453A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Phase N/A · 1 location(s) · Almirall, S.A. · NCT06029257Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · 2 location(s) · Seismic Therapeutic AU Pty Ltd · NCT07455578A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Se
Phase N/A · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06987292Molecular Inflammation Board at the Center for Personalized Medicine
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT07132333Modifying PEST for Psoriatic Arthritis Screening
NA · 30 location(s) · Novartis Pharmaceuticals · NCT06382051Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Phase N/A · 6 location(s) · Chronicle Academy · NCT07370766PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
Phase N/A · 2 location(s) · CorEvitas · NCT07648602Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06801821SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Phase N/A · 8 location(s) · Leiden University Medical Center · NCT07021495Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study
EARLY_Phase 1 · 1 location(s) · Alexandria University · NCT07169019A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Ye
Phase 3 · 50 location(s) · UCB Biopharma SRL · NCT06425549Effect of Semaglutide in Patients With Psoriasis and Obesity
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06937060A Study to Assess Deucravacitinib Safety in Pregnancy
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07017699The Effects of Audio-Based Therapy on Anxiety in Psoriasis
NA · 1 location(s) · University of California, San Francisco · NCT07390487PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
Phase N/A · 1 location(s) · CorEvitas · NCT07615712Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Phase 1 · 3 location(s) · LAPIX Therapeutics Inc. · NCT06982352
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.